PORTAGE BIOTECH INC. Quarterly Research And Development Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
ifrs-full: USD
Summary
Portage Biotech Inc. quarterly/annual Research And Development Expense history and growth rate from Q2 2020 to Q1 2024.
  • Portage Biotech Inc. Research And Development Expense for the quarter ending March 31, 2024 was $1.9M, a 29.6% decline year-over-year.
  • Portage Biotech Inc. Research And Development Expense for the twelve months ending March 31, 2024 was $12.5M, a 44.5% increase year-over-year.
  • Portage Biotech Inc. annual Research And Development Expense for 2023 was $12.5M, a 44.5% increase from 2022.
  • Portage Biotech Inc. annual Research And Development Expense for 2022 was $8.67M, a 28.1% increase from 2021.
  • Portage Biotech Inc. annual Research And Development Expense for 2021 was $6.77M, a 7.43% decline from 2020.
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $12.5M $1.9M -$798K -29.6% Jan 1, 2024 Mar 31, 2024 20-F 2024-08-14
Q4 2023 $13.3M $2.77M +$236K +9.31% Oct 1, 2023 Dec 31, 2023 6-K 2024-02-28
Q3 2023 $13.1M $4.24M +$2.67M +171% Jul 1, 2023 Sep 30, 2023 6-K 2023-11-28
Q2 2023 $10.4M $3.63M +$1.75M +93.3% Apr 1, 2023 Jun 30, 2023 6-K 2023-08-29
Q1 2023 $8.67M $2.7M +$733K +37.3% Jan 1, 2023 Mar 31, 2023 20-F 2024-08-14
Q4 2022 $7.94M $2.54M +$607K +31.5% Oct 1, 2022 Dec 31, 2022 6-K 2024-02-28
Q3 2022 $7.33M $1.57M +$235K +17.7% Jul 1, 2022 Sep 30, 2022 6-K 2023-11-28
Q2 2022 $7.1M $1.88M +$330K +21.3% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-29
Q1 2022 $6.77M $1.97M -$3.69M -65.2% Jan 1, 2022 Mar 31, 2022 20-F 2024-08-14
Q4 2021 $10.5M $1.93M +$1.51M +366% Oct 1, 2021 Dec 31, 2021 6-K 2023-03-01
Q3 2021 $8.94M $1.33M +$538K +67.9% Jul 1, 2021 Sep 30, 2021 6-K 2022-11-29
Q2 2021 $8.41M $1.55M +$1.09M +242% Apr 1, 2021 Jun 30, 2021 6-K 2022-08-29
Q1 2021 $7.31M $5.65M Jan 1, 2021 Mar 31, 2021 20-F 2023-07-31
Q4 2020 $414K Oct 1, 2020 Dec 31, 2020 6-K 2022-02-25
Q3 2020 $792K Jul 1, 2020 Sep 30, 2020 6-K 2021-11-23
Q2 2020 $452K Apr 1, 2020 Jun 30, 2020 6-K 2021-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.